Makers Laboratories Ltd - Financial Result for the Quarter ended 30th Jun'26 (Consolidated, INR Lacs)
Makers Laboratories Ltd · Outcome · 07 Aug 2026, 5:32 pm
Makers Laboratories Ltd - Financial Result for the Quarter ended 30th Jun'26 (Consolidated, INR Lacs) ■ Revenue: 4,277 (+22.2% YoY | +19.6% QoQ) ■ EBITDA: 696 (+131.1% YoY | +32.0% QoQ) ■ EBITDA Margin (%): 16.3 (+767 bps YoY | +153 bps QoQ) ■ PAT: 150 (+244.5% YoY | +37.6% QoQ) ■ EPS (INR): 2.55 (+244.6% YoY | +37.8% QoQ) Makers Laboratories Ltd - Financial Result for the Quarter ended 30th Jun'26 (Consolidated, INR Lacs) Segmental Performance Pharmaceutical ■ Revenue: 1,026 (-25.5% YoY | -9.2% QoQ) ■ EBIT: -126 (-319.7% YoY | -8.3% QoQ) ■ EBIT Margin (%): -12.3 (-1008 bps YoY | -198 bps QoQ) Chemical Manufacturing ■ Revenue: 3,312 (+54.0% YoY | +31.4% QoQ) ■ EBIT: 755 (+231.9% YoY | +28.1% QoQ) ■ EBIT Margin (%): 22.8 (+1222 bps YoY | -58 bps QoQ)
Original exchange filing (PDF)
More announcements from Makers Laboratories Ltd
- Standalone and Consolidated Financial Results for second quarter and half year ended 30.09.2026 · 04 Nov 2026
- Standalone and Consolidated Financial Results for second quarter and half year ended 30.09.2026 · 04 Nov 2026
- Makers Laboratories Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2026 ,inter alia, to consider and approve Standalone and Consolidated .... · 04 Nov 2026
- Credit Rating for Bank Facilities · 01 Sept 2026
- Voting Results and Scrutinizer Report · 07 Aug 2026
- 41st Annual General Meeting of the Company · 07 Aug 2026
- Change in Directorship of Mr. Saahil Parikh from Wholetime Director to Non-Executive, Non-Independent Wholetime Director · 07 Aug 2026
- Standalone and Consolidated Financial Results for Q1FY27 · 07 Aug 2026
